Efficacy and safety of tafamidis doses in the <scp>Tafamidis in Transthyretin Cardiomyopathy Clinical Trial</scp> ( <scp>ATTR‐ACT</scp> ) and long‐term extension study

2020204 citationsJournal Articlehybrid Open Access

Authors

ClinicalTrials.gov NCT01994889; NCT02791230.

Good health and well-being

Published in: European Journal of Heart Failure

Volume 23, Issue 2, pp. 277-285

Field-Weighted Citation Impact: 8.92